Correlation between the Japanese Aging Male Questionnaire (JAMQ) and Aging Male’s Symptom (AMS) scale in Japanese male

Reference

• Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995–2010
   PubMed Web of Science ®Google Scholar
• Novak A, Brod M, Elbers J. Andropause and quality of life: findings from patient focus groups and clinical experts. Maturitas 2002;43:231–7
   PubMed Web of Science ®Google Scholar
• Horie S. Low testosterone level in men and quality of life. In: Preedy VR, Watson RR, eds. Handbook of disease burdens and quality of life measures. New York: Springer; 2010:2615--31
   Google Scholar
• Morales A, Lunenfeld B. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74–86
   PubMedGoogle Scholar
• Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2005;8:56–8
   PubMedGoogle Scholar
• Wang C, Nieschlag E, Swerdloff RS, et al. ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 2009;12:5–12
   PubMed Web of Science ®Google Scholar
• Seftel AD. Male hypogonadism. Part I: Epidemiology of hypogonadism. Int J Impot Res 2006;18:115–20
   PubMed Web of Science ®Google Scholar
• Heinemann L, Zimmermann T, Vermeulen A, Thiel C. A new “Aging Males Symptoms” (AMS) rating scale. The Aging Male 1999;2:105–14
   Google Scholar
• Heinemann LA, Saad F, Zimmermann T, et al. The Aging Males’ Symptoms (AMS) scale: update and compilation of international versions. Health Qual Life Outcomes 2003;1:15
   PubMedGoogle Scholar
• Moore C, Huebler D, Zimmermann T, et al. The Aging Males’ Symptoms scale (AMS) as outcome measure for treatment of androgen deficiency. Eur Urol 2004;46:80–7
   PubMed Web of Science ®Google Scholar
• Maruyama O, Ide H, Yoshi T, et al. The efficacy of ‘Aging Male Questionnaire’ (Kumamoto) for Japanese PADAM patients. The Aging Male 2006;9:19
   Google Scholar
• Kratzik C, Heinemann LA, Saad F, et al. Composite screener for androgen deficiency related to the Aging Males’ Symptoms scale. Aging Male 2005;8:157–61
   PubMedGoogle Scholar
• Hisasue S, Kumamoto Y, Sato Y, et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005;65:143–8
   PubMed Web of Science ®Google Scholar
• Yokoyama K, Araki S, Matusoka K, et al. Socioeconomic factors affecting alcohol consumption in Japan. Alcoholism 1999;35:13–22
   Google Scholar
• Takeuchi T, Nakao M, Nishikitani M, Yano E. Stress perception and social indicators for low back, shoulder and joint pains in Japan: national surveys in 1995 and 2001. Tohoku J Exp Med 2004;203:195–204
   PubMedGoogle Scholar
• Daig I, Heinemann LA, Kim S, et al. The Aging Males’ Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes 2003;1:77 . doi:10.1186/1477-7525-1-77
   PubMedGoogle Scholar
• Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations. Eur Urol 2005;48:1–4
   PubMed Web of Science ®Google Scholar
• Lunenfeld B, Saad F, Hoesl C. ISM, ISSAM, and EAU recommendations for the investigation and monitoring of late-onset hypogonadism in males: scientific background and rationale. The Aging Male 2005;8:59–74
   PubMedGoogle Scholar
• Duncan A, Hays T. The development of a men’s health center at an integrated academic health center. The J Men’s Health Gender 2005;2:17–20
   Google Scholar
• Rhoden EL, Morgentaler A. Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 2004;350:482–92
   PubMed Web of Science ®Google Scholar
• Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–81
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724–31
   PubMed Web of Science ®Google Scholar
• Gao HB, Shan LX, Monder C, Hardy MP. Suppression of endogenous corticosterone levels in vivo increases the steroidogenic capacity of purified rat Leydig cells in vitro. Endocrinology 1996;137:1714–8
   PubMed Web of Science ®Google Scholar
• Kawa G, Taniguchi H, Kinoshita H, et al. Aging male symptoms and serum testosterone levels in healthy Japanese middle-aged men. Nihon Hinyokika Gakkai Zasshi 2008;99:645–51
   PubMedGoogle Scholar
• Kobayashi K, Hashimoto K, Kato R, et al. The Aging Males’ Symptoms scale for Japanese men: reliability and applicability of the Japanese version. Int J Impot Res 2008;20:544–8
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Kato R, Hashimoto K, et al. Factor analysis of the Japanese version of the Aging Males' Symptoms rating scale. Hinyokika Kiyo 2009;55:475–8
   PubMedGoogle Scholar
• Gacci M, Eardley I, Giuliano F, et al. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol 2011;60:809–25
   PubMed Web of Science ®Google Scholar
• Holm AC, Fredrikson MG, Theodorsson E, et al. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism. Aging Male 2011;14:249–56
   PubMed Web of Science ®Google Scholar